Feed / AVAH

Aveanna Healthcare Holdings Inc.

AVAH

Healthcare · 13.88 -1.1% today

Isolated · not yet confirmedMarket checked 10 Sept, 15:55 GMT-4

Market read

Aveanna Healthcare Holdings Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 2 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 0 directly disclosed connections are confirming.

Company-1.1% todayVolume comparison unavailable
Market group0 of 2 activeHealthcare Facilities · unavailable
Disclosed network0 of 0 confirmingRelationship data unavailable
What would change this read
  • AVAH's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if AVAH's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Healthcare · Medical Care Facilities

No new filing conclusion is available. 0 of 2 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 0 directly disclosed connections are confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • AVAH's market-adjusted activity becomes unusual and at least one connected name confirms.

Company research

Understand the business, not just the ticker

As of Sep 11, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods7
Price observations319
Usable filing statements109
Verified relationships0
Evidence supporting the case
  • Latest annual revenue changed +20.2% year over year.
  • Operating margin changed +3.6 percentage points in the latest annual period.
  • Net margin changed +9.8 percentage points in the latest annual period.
  • Demand and volume has repeated favorable evidence across 4 filings.
Evidence challenging the case
  • Diluted shares increased 11.4% in the latest annual period.
  • Credit and interest rates has repeated adverse evidence across 4 filings.
Questions before a position

No credible peer-relative valuation comparison is available yet.

Longer-term price context

Price as of Sep 10, 2026

13.88
6m+88.6%12m+76.8%24m
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2022-01-01$1.7B+12.3%$-0.69
2022-12-31$1.8B+6.5%$-3.57+8.7%
2023-12-30$1.9B+6.0%$-0.71+2.4%
2024-12-28$2.0B+6.8%$-0.06+1.5%
2026-01-03$2.4B+20.2%$1.05+11.4%

What management says matters

Persistent and emerging business drivers

Credit and interest ratesnegative · 4 filings
The decrease was primarily driven by a lower U.S.
10-Q · May 14, 2026
Demand and volumepositive · 4 filings
The 10.7% increase in volume was primarily attributable to growth in demand for non-clinical services and new volumes attributable to the Thrive acquisition which was completed on June 2, 2025.
10-Q · May 14, 2026
Supply chain and availabilitymixed · 4 filings
Subsequent changes resulting from a patient’s ability to pay are recorded as bad debt expense, which is included as a component of operating expenses in the consolidated statements of operations.
10-Q · May 14, 2026
Restructuring and cost reductionsnegative · 2 filings
79 During the fiscal years ended January 3, 2026 and December 28, 2024, the Company recorded asset impairment charges related to previously acquired licenses due to their surrender and the closure of related branches of $ 1.9 million and $ 3.2 million, respec…
10-K · Mar 19, 2026

Valuation discipline

Peer-relative valuation withheld

Jodie found no industry-matched filing peers suitable for a valuation comparison. It will not substitute broader financial-sector names.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

13.88-1.1% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 10 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for AVAH. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for AVAH. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind AVAH

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Filing peers

No filing peers are available for this name yet.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

AVAH is currently a Leader in the organic co-movement group Healthcare Facilities. This group is discovered from market behaviour rather than assigned from an industry taxonomy. No verified filing-linked names are available yet.

This group is retained as the last observed read for AVAH; it is not active in the latest market snapshot.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.